DE2036687A1 - C\clotrisiloxane mit Gemtalfunktionen von Saugetieren verändernder Wirkung - Google Patents
C\clotrisiloxane mit Gemtalfunktionen von Saugetieren verändernder WirkungInfo
- Publication number
- DE2036687A1 DE2036687A1 DE19702036687 DE2036687A DE2036687A1 DE 2036687 A1 DE2036687 A1 DE 2036687A1 DE 19702036687 DE19702036687 DE 19702036687 DE 2036687 A DE2036687 A DE 2036687A DE 2036687 A1 DE2036687 A1 DE 2036687A1
- Authority
- DE
- Germany
- Prior art keywords
- mammals
- dichloro
- diphenyltetramethyltrisiloxane
- clotrisiloxane
- cis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000694 effects Effects 0.000 title description 8
- 241000124008 Mammalia Species 0.000 title description 7
- 238000010422 painting Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 12
- JJRDHFIVAPVZJN-UHFFFAOYSA-N cyclotrisiloxane Chemical compound O1[SiH2]O[SiH2]O[SiH2]1 JJRDHFIVAPVZJN-UHFFFAOYSA-N 0.000 claims description 8
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 claims description 4
- 239000002798 polar solvent Substances 0.000 claims description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- 239000003054 catalyst Substances 0.000 claims description 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 239000004927 clay Substances 0.000 claims description 2
- 238000009833 condensation Methods 0.000 claims description 2
- 230000005494 condensation Effects 0.000 claims description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 2
- 239000005051 trimethylchlorosilane Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 5
- 125000004122 cyclic group Chemical group 0.000 claims 1
- GNEPOXWQWFSSOU-UHFFFAOYSA-N dichloro-methyl-phenylsilane Chemical compound C[Si](Cl)(Cl)C1=CC=CC=C1 GNEPOXWQWFSSOU-UHFFFAOYSA-N 0.000 claims 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 238000004821 distillation Methods 0.000 description 7
- 210000000056 organ Anatomy 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- -1 Nitrome.than Natural products 0.000 description 5
- 238000004587 chromatography analysis Methods 0.000 description 5
- 230000035935 pregnancy Effects 0.000 description 5
- 230000001568 sexual effect Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 210000002307 prostate Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- 229910018557 Si O Inorganic materials 0.000 description 2
- 229910002808 Si–O–Si Inorganic materials 0.000 description 2
- 206010000210 abortion Diseases 0.000 description 2
- 231100000176 abortion Toxicity 0.000 description 2
- 239000003098 androgen Substances 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N anhydrous diethylene glycol Natural products OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- LIVNPJMFVYWSIS-UHFFFAOYSA-N silicon monoxide Inorganic materials [Si-]#[O+] LIVNPJMFVYWSIS-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000009987 spinning Methods 0.000 description 2
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 1
- AVFZNEFGPNKYDD-UHFFFAOYSA-N 2,2,4,6-tetramethyl-4,6-diphenyl-1,3,5,2,4,6-trioxatrisilinane Chemical compound O1[Si](C)(C)O[Si](C)(C=2C=CC=CC=2)O[Si]1(C)C1=CC=CC=C1 AVFZNEFGPNKYDD-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282421 Canidae Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical class COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010067572 Oestrogenic effect Diseases 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 229910018540 Si C Inorganic materials 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- YZDAFWLIMRVDNP-UHFFFAOYSA-N acetonitrile;n,n-dimethylacetamide Chemical compound CC#N.CN(C)C(C)=O YZDAFWLIMRVDNP-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001548 androgenic effect Effects 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 150000001923 cyclic compounds Chemical class 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 201000001514 prostate carcinoma Diseases 0.000 description 1
- 239000005297 pyrex Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000001625 seminal vesicle Anatomy 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000000707 stereoselective effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 238000002627 tracheal intubation Methods 0.000 description 1
- ZQTYRTSKQFQYPQ-UHFFFAOYSA-N trisiloxane Chemical group [SiH3]O[SiH2]O[SiH3] ZQTYRTSKQFQYPQ-UHFFFAOYSA-N 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 201000010653 vesiculitis Diseases 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/12—Organo silicon halides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/21—Cyclic compounds having at least one ring containing silicon, but no carbon in the ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84418569A | 1969-07-23 | 1969-07-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2036687A1 true DE2036687A1 (de) | 1971-02-11 |
Family
ID=25292060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19702036687 Pending DE2036687A1 (de) | 1969-07-23 | 1970-07-23 | C\clotrisiloxane mit Gemtalfunktionen von Saugetieren verändernder Wirkung |
Country Status (6)
| Country | Link |
|---|---|
| AT (1) | AT298509B (enrdf_load_stackoverflow) |
| BE (1) | BE753748A (enrdf_load_stackoverflow) |
| DE (1) | DE2036687A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2059550B1 (enrdf_load_stackoverflow) |
| GB (1) | GB1256998A (enrdf_load_stackoverflow) |
| NL (1) | NL7010862A (enrdf_load_stackoverflow) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4843603B1 (enrdf_load_stackoverflow) * | 1968-07-10 | 1973-12-19 |
-
1970
- 1970-06-02 GB GB1256998D patent/GB1256998A/en not_active Expired
- 1970-07-22 FR FR7027065A patent/FR2059550B1/fr not_active Expired
- 1970-07-22 BE BE753748D patent/BE753748A/xx unknown
- 1970-07-22 NL NL7010862A patent/NL7010862A/xx unknown
- 1970-07-23 DE DE19702036687 patent/DE2036687A1/de active Pending
- 1970-07-23 AT AT675370A patent/AT298509B/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NL7010862A (enrdf_load_stackoverflow) | 1971-01-26 |
| FR2059550B1 (enrdf_load_stackoverflow) | 1974-02-01 |
| BE753748A (fr) | 1971-01-22 |
| AT298509B (de) | 1972-05-10 |
| FR2059550A1 (enrdf_load_stackoverflow) | 1971-06-04 |
| GB1256998A (enrdf_load_stackoverflow) | 1971-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0017121B1 (de) | Neue quartäre Polysiloxanderivate, deren Verwendung in Haarkosmetika, sowie diese enthaltende Haarwasch- und Haarbehandlungsmittel | |
| DE2500110A1 (de) | 3-aryloxy-3-phenylpropylamine und verfahren zu ihrer herstellung | |
| DE3490215C2 (enrdf_load_stackoverflow) | ||
| DE69629928T2 (de) | Verfahren zur herstellung jodierter fettsäuren und ihrer derivate durch jodwasserstoffanlagerung unter anwendung von alkylsilylderivaten mit alkalijodiden und deren pharmakologischen aktivitäten | |
| DE2036616C3 (de) | Verfahren zur Herstellung von Cyclosiloxanen | |
| DE2036687A1 (de) | C\clotrisiloxane mit Gemtalfunktionen von Saugetieren verändernder Wirkung | |
| DE2923604A1 (de) | Verfahren zur herstellung von silicium enthaltenden derivaten des acetamids | |
| DE2134085C3 (de) | Spiramycin-hydrazone | |
| DE69917769T2 (de) | Verfahren zur Herstellung von Lösungen von Antitranspirantsalzen in Silikonlösemitteln | |
| DE2422612C3 (de) | .Verwendung von 2,6-trans-Diphenylhexamethylcyclotetrasiloxan zur Herstellung eines oral oder intravenös verabreichbaren Arzneimittels zur Erhöhung des Dopamingehalts fan Gehirn von Tieren | |
| DE2633926A1 (de) | Hydantoinverbindungen und mittel, die diese enthalten | |
| DE2157399A1 (de) | Anaesthetica | |
| DE2157400A1 (de) | Anaesthetica | |
| DE2012683B2 (de) | Verfahren zur reinigung von gemischen von organochlorsilanen | |
| DE2317183C2 (de) | Benzylamin-analgetika | |
| DE2247399A1 (de) | Chemische verbindungen | |
| DE1933110C3 (de) | Mittel zur Verminderung der androgenen Kapazität von männlichen Säugetieren | |
| DE2422430C3 (de) | Derivate der Secalonsäure D, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Bekämpfung von Tumoren | |
| DE2538593C3 (de) | m-Trifluormethylthio-phenäthylaminderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE69705055T2 (de) | 1,3-dioxan derivate, verfahren zu ihrer herstellung und aromatisierende zusammensetzungen die diese enthalten | |
| AT254166B (de) | Verfahren zur Herstellung von neuen 5-(3'-sek.Aminopropyl)-5H-dibenzo[a,d]cycloheptenen bzw. den 10,11-Dihydroderivaten derselben | |
| DE2327901A1 (de) | Halocyclopropane | |
| DE2236491C3 (de) | 2,4-Disubstituierte 2H-Thiapyrane bzw. deren 1-Oxide, Verfahren zu ihrer Herstellung sowie deren Verwendung | |
| DE2327902A1 (de) | Halocyclopropane | |
| DE2010222C (de) | Äther des Salicylamide und Verfahren zu deren Herstellung |